Dr David Avigan at ASH 2014: New hope in myeloma treatment

Dr David Avigan at ASH 2014: New hope in myeloma treatment

Published:

ASH 2014: Dr Andrew Davies gives an update of the new oral drug, idelalisib, in indolent lymphomas

ASH 2014: Dr Andrew Davies gives an update of the new oral drug, idelalisib, in indolent lymphomas

Published:

Dr Jean-Jacques Kiladjian at ASH 2014: New therapies for polycythaemia vera (PV)

Dr Jean-Jacques Kiladjian at ASH 2014: New therapies for polycythaemia vera (PV)

Published:

Nuove speranze per i pazienti di linfoma mantellare

Nuove speranze per i pazienti di linfoma mantellare

Published:

Resultados esperanzadores de un nuevo tratamiento para pacientes de mieloma en recaída

Resultados esperanzadores de un nuevo tratamiento para pacientes de mieloma en recaída

Published:

Avances en el tratamiento del mieloma presentados en ASH

Avances en el tratamiento del mieloma presentados en ASH

Published:

Dr Andrew Davies at ASH 2014: New hope for patients with indolent lymphomas

Dr Andrew Davies at ASH 2014: New hope for patients with indolent lymphomas

Published:

Impatto dei nuovi farmaci nei trattamento di pazienti con neoplasie ematologiche

Impatto dei nuovi farmaci nei trattamento di pazienti con neoplasie ematologiche

Published:

New drugs showing promise for CLL patients at ASH 2014: A discussion between Prof John Gribben and Prof Peter Hillmen

New drugs showing promise for CLL patients at ASH 2014: A discussion between Prof John Gribben and Prof Peter Hillmen

Published:

Dr Barbara Eichhorst at ASH 2014: New therapies for CLL, including ABT-199, ibrutinib and idelalisib

Dr Barbara Eichhorst at ASH 2014: New therapies for CLL, including ABT-199, ibrutinib and idelalisib

Published:

Prof John Gribben and Prof Peter Hillmen at ASH 2014: New combination therapies provide great opportunities for CLL

Prof John Gribben and Prof Peter Hillmen at ASH 2014: New combination therapies provide great opportunities for CLL

Published:

Dr Barbara Eichhorst at ASH 2014: The international phase III CLL10 study

Dr Barbara Eichhorst at ASH 2014: The international phase III CLL10 study

Published:

Prof Anton Hagenbeek at ASH 2014: Good news for managing lymphoma in the clinic

Prof Anton Hagenbeek at ASH 2014: Good news for the management of lymphoma

Published:

Dr George Follows at ASH 2014: Latest developments in CLL

Dr George Follows at ASH 2014: Latest developments in CLL

Published:

Prof Christian Gisselbrecht at ASH 2014: Getting research from bench to bedside

Prof Christian Gisselbrecht at ASH 2014: Getting research from bench to bedside

Published:

Prof John Gribben and Prof Peter Hillmen at ASH 2014: Early treatment versus ‘watch and wait’ for CLL

Prof John Gribben and Prof Peter Hillmen at ASH 2014: Early treatment versus ‘watch and wait’ for CLL

Published:


Page last updated on January 26, 2016